Abingworth is a venture capital firm founded in 1973. The firm's headquarters is located in London, United Kingdom, with additional offices in the United States at San Francisco and Boston. As of October 2019, Abingworth has sold off its ownership in 134 companies and is currently managing a portfolio of 25 companies.
Abingworth focuses on funding companies based in Europe and the United States. Sector-wise, Abingworth provides funding for companies in the life sciences industry, with a specific interest in fields such as biotherapeutics, small molecules, nucleic acid therapeutics, and vaccines. For each company, the firm allocates an investment total at a range of $15-$30 million.
Labcyte is a global biotechnology tools company headquartered in San Jose, California, that develops tools for liquid handling.
A company focused on development of products to treat central nervous system disorders, pain and rare diseases
A company developing therapies for psychological and neurological illnesses
An independent vaccine platform in California that focuses on delivering best-in-class conjugate vaccines and complex antigen-based vaccines to prevent deadly infectious diseases.
A company focused on the discovery and development of treatments for rare inherited diseases.
Avedro is a Waltham, Massachusetts-based company.
A molecular diagnostics for oncology company
A company developing RNA-based therapeutics for genetic disorders, infections and cancer
A company dedicated on the discovery and development of small molecule therapeutics to treat cancer
A biopharmaceutical company developing small molecule drugs for asthma, chronic allergy and inflammatory conditions
VirionHealth is a biotechnology company
VenatoRx Pharmaceuticals is a Malvern, Pennsylvania-based company.
Gynesonics is a Redwood City, California-based healthcare company.
Chiasma Pharma is a Waltham, Massachusetts-based company.
Wilson Therapeutics is a Burlington, Massachusetts-based company.
Partner, Portfolio Manager
Partner and CFO
Partner and General Counsel
Kurt von Emster
Partner, Marketing and Talent
Chairman & Managing Partner